69 related articles for article (PubMed ID: 31434944)
1. Prognostic values of novel biomarkers in patients with AL amyloidosis.
Kim D; Lee GY; Choi JO; Kim K; Kim SJ; Ju ES; Jeon ES
Sci Rep; 2019 Aug; 9(1):12200. PubMed ID: 31434944
[TBL] [Abstract][Full Text] [Related]
2. Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study.
Zaroui A; Kharoubi M; Gounot R; Oghina S; Degoutte C; Bezard M; Galat A; Guendouz S; Roulin L; Audard V; Leroy V; Teiger E; Poullot E; Molinier-Frenkel V; Le Bras F; Belhadj K; Bastard JP; Fellahi S; Shourick J; Lemonier F; Damy T
ESC Heart Fail; 2024 Jun; 11(3):1707-1719. PubMed ID: 38444090
[TBL] [Abstract][Full Text] [Related]
3. The Role of Biomarkers in Predicting Cognitive Impairment in Elderly Patients with Heart Failure.
Arslan A; Çelik A; Döven O
Turk Kardiyol Dern Ars; 2024 Jun; 52(4):244-252. PubMed ID: 38829644
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular myocardial work improves in response to treatment and is associated with survival among patients with light chain cardiac amyloidosis.
Briasoulis A; Bampatsias D; Petropoulos I; Rempakos A; Patras R; Theodorakakou F; Makris N; Dimopoulos MA; Stamatelopoulos K; Kastritis E
Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):698-707. PubMed ID: 38142437
[TBL] [Abstract][Full Text] [Related]
5. The Real-World Data on Patients With Cardiac Stage IIIb AL Amyloidosis.
Hong Y; Guo J; Chen W; Zhao L; Liu Z; Huang X
Clin Lymphoma Myeloma Leuk; 2024 May; ():. PubMed ID: 38806310
[TBL] [Abstract][Full Text] [Related]
6. Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis.
Zhang KW; Miao J; Mitchell JD; Alvarez-Cardona J; Tomasek K; Su YR; Gordon M; Cornell RF; Lenihan DJ
JACC CardioOncol; 2020 Mar; 2(1):56-66. PubMed ID: 33283202
[TBL] [Abstract][Full Text] [Related]
7. Serum alpha 1 antitrypsin potent act as an early diagnostic biomarker for cardiac amyloidosis.
Zhu Y; Yuan H; Qu H
Heart Vessels; 2024 Apr; ():. PubMed ID: 38580850
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic and bleeding complications in patients with AL amyloidosis.
Fotiou D; Theodorakakou F; Spiliopoulou S; Gavriatopoulou M; Migkou M; Kanellias N; Eleutherakis-Papaiakovou E; Malandrakis P; Dialoupi I; Roussou M; Ntanasis-Stathopoulos I; Terpos E; Dimopoulos MA; Kastritis E
Br J Haematol; 2024 May; 204(5):1816-1824. PubMed ID: 38321638
[TBL] [Abstract][Full Text] [Related]
9. Limited utility of Mayo 2012 cardiac staging system for risk stratification of patients with advanced cardiac AL amyloidosis - analysis of a uniformly treated cohort of 1,275 patients.
Khwaja J; Ravichandran S; Bomsztyk J; Cohen O; Foard D; Martinez-Naharro A; Venneri L; Fontana M; Hawkins PN; Gillmore J; Lachmann HJ; Mahmood S; Whelan C; Kirkwood AA; Wechalekar A
Haematologica; 2024 May; 109(5):1598-1602. PubMed ID: 38205538
[No Abstract] [Full Text] [Related]
10. [Clinical characteristics and prognostic analysis of monoclonal IgM-related AL amyloidosis].
Mao YY; Feng J; Meng Q; Shen KN; Cao XX; Zhou DB; Li J
Zhonghua Xue Ye Xue Za Zhi; 2017 Nov; 38(11):989-992. PubMed ID: 29224328
[No Abstract] [Full Text] [Related]
11. Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis.
Okada M; Misumi Y; Masuda T; Takashio S; Tasaki M; Matsushita H; Ueda A; Inoue Y; Nomura T; Nakajima M; Yamashita T; Shinriki S; Matsui H; Tsujita K; Ando Y; Ueda M
ESC Heart Fail; 2021 Apr; 8(2):1178-1185. PubMed ID: 33381924
[TBL] [Abstract][Full Text] [Related]
12. Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.
Wischhusen J; Melero I; Fridman WH
Front Immunol; 2020; 11():951. PubMed ID: 32508832
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2022 Jun; 97(6):818-829. PubMed ID: 35429180
[TBL] [Abstract][Full Text] [Related]
14. A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis.
Ríos-Tamayo R; Lecumberri R; Cibeira MT; González-Calle V; Alonso R; Domingo-González A; Landete E; Encinas C; Iñigo B; Blanchard MJ; Alejo E; Krsnik I; Gómez-Bueno M; Garcia-Pavia P; Segovia-Cubero J; Rosiñol L; Lahuerta JJ; Martínez-López J; Bladé J
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730641
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study.
Nicol M; Vergaro G; Damy T; Kharoubi M; Baudet M; Canuti ES; Aimo A; Castiglione V; Emdin M; Royer B; Harel S; Cohen-Solal A; Arnulf B; Logeart D
Front Cardiovasc Med; 2023; 10():1179968. PubMed ID: 37600055
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mid-term clinical outcome in heart transplantation patients using mycophenolate mofetil vs. enteric-coated mycophenolate sodium.
Jeon K; Kim D; Choi JO; Cho YH; Sung K; Oh J; Cho HJ; Jung SH; Lee HY; Park JJ; Choi DJ; Kang SM; Kim JJ; Jeon ES
Front Cardiovasc Med; 2022; 9():957299. PubMed ID: 36082128
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis.
Bak M; Kim D; Choi JO; Kim K; Kim SJ; Jeon ES
Front Cardiovasc Med; 2022; 9():904878. PubMed ID: 35811735
[TBL] [Abstract][Full Text] [Related]
18. An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study.
Richards D; Millns H; Cookson L; Lukas MA
Orphanet J Rare Dis; 2022 Jul; 17(1):259. PubMed ID: 35810311
[TBL] [Abstract][Full Text] [Related]
19. Multimodal Imaging and Biomarkers in Cardiac Amyloidosis.
Jung MH; Chang S; Han EJ; Youn JC
Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328180
[TBL] [Abstract][Full Text] [Related]
20. Management of Amyloid Cardiomyopathy in Resource-Constrained Settings: Challenges and Opportunities.
Singh S; Tandon R; Mohan B
JACC CardioOncol; 2021 Oct; 3(4):611-613. PubMed ID: 34729537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
